GRIMES & COMPANY, INC. - Genomed Inc. ownership

Genomed Inc.'s ticker is GMED and the CUSIP is 37243C102. A total of 1 filers reported holding Genomed Inc. in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GRIMES & COMPANY, INC. ownership history of Genomed Inc.
ValueSharesWeighting
Q1 2019$012,4250.0%0.00%
Q4 2018$012,4250.0%0.00%
Q3 2018$012,4250.0%0.00%
Q2 2018$012,4250.0%0.00%
Q1 2018$012,4250.00%
Other shareholders
Genomed Inc. shareholders Q1 2019
NameSharesValueWeighting ↓
GRIMES & COMPANY, INC. 12,425$00.00%
View complete list of Genomed Inc. shareholders